These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 25492095)
1. Improvement in lung function is associated with a decrease in serum soluble CD30 in atopic infants. Kotaniemi-Syrjänen A; Delezuch W; Pelkonen AS; Malmström K; Malmberg LP; Punnonen K; Matinlauri IH; Mäkelä MJ Ann Allergy Asthma Immunol; 2015 Feb; 114(2):156-7. PubMed ID: 25492095 [No Abstract] [Full Text] [Related]
2. Association of serum-soluble CD26 and CD30 levels with asthma, lung function and bronchial hyper-responsiveness at school age. Remes ST; Delezuch W; Pulkki K; Pekkanen J; Korppi M; Matinlauri IH Acta Paediatr; 2011 Sep; 100(9):e106-11. PubMed ID: 21401715 [TBL] [Abstract][Full Text] [Related]
3. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age. Heshmat NM; El-Hadidi ES Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784 [TBL] [Abstract][Full Text] [Related]
5. Serum and CSF soluble CD26 and CD30 concentrations in healthy pediatric surgical outpatients. Delezuch W; Marttinen P; Kokki H; Heikkinen M; Vanamo K; Pulkki K; Matinlauri I Tissue Antigens; 2012 Oct; 80(4):368-75. PubMed ID: 22861386 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous CD30+ cells in children with atopic dermatitis. Cavagni G; Caffarelli C; Facchetti F; Brugnoni D; Notarangelo LD; Tosoni C; Altobelli R Int Arch Allergy Immunol; 2000 Mar; 121(3):224-8. PubMed ID: 10729781 [TBL] [Abstract][Full Text] [Related]
7. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26. Katoh N; Hirano S; Suehiro M; Ikenaga K; Yamashita T; Sugawara N; Yasuno H Clin Exp Immunol; 2000 Aug; 121(2):187-92. PubMed ID: 10931130 [TBL] [Abstract][Full Text] [Related]
8. Soluble CD26 and CD30 levels in patients with common variable immunodeficiency. Mahmoudi M; Hedayat M; Aghamohammadi A; Rezaei N J Investig Allergol Clin Immunol; 2013; 23(2):120-4. PubMed ID: 23654079 [TBL] [Abstract][Full Text] [Related]
9. Changes in plasma soluble CD26 and CD30 during pregnancy: markers of Th1/Th2 balance? Hoshimoto K; Ohta N; Ohkura T; Inaba N Gynecol Obstet Invest; 2000; 50(4):260-3. PubMed ID: 11093050 [TBL] [Abstract][Full Text] [Related]
10. CD26 and CD30 expression on the surface of lymphocyte during normal pregnancy. Hoshimoto K; Hayashi M; Ohkura T Gynecol Obstet Invest; 2001; 52(1):9-12. PubMed ID: 11549856 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of soluble CD26 and CD30 in patients on hemodialysis. Nakao K; Nagake Y; Okamoto A; Ichikawa H; Yamamura M; Makino H Nephron; 2002 Jun; 91(2):215-21. PubMed ID: 12053056 [TBL] [Abstract][Full Text] [Related]
12. Exhaled breath condensate pH measurement in children with asthma, allergic rhinitis and atopic dermatitis. Brunetti L; Francavilla R; Tesse R; Strippoli A; Polimeno L; Loforese A; Miniello VL; Armenio L Pediatr Allergy Immunol; 2006 Sep; 17(6):422-7. PubMed ID: 16925687 [TBL] [Abstract][Full Text] [Related]
13. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis. Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453 [TBL] [Abstract][Full Text] [Related]
14. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis. Kwakkel-van Erp JM; Haeck IM; Paantjens AW; van de Graaf EA; van Ginkel WG; Knol MJ; de Bruin-Weller MS; Lammers JW; Knol EF; Bruijnzeel-Koomen C; Otten HG J Am Acad Dermatol; 2010 Sep; 63(3):e70-2. PubMed ID: 20708466 [No Abstract] [Full Text] [Related]
15. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index. Di Lorenzo G; Gangemi S; Merendino RA; Minciullo PL; Cannavò SP; Martinelli N; Mansueto P; Rini GB; Corrocher R; Pacor ML Mediators Inflamm; 2003 Apr; 12(2):123-5. PubMed ID: 12775363 [TBL] [Abstract][Full Text] [Related]
16. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Pellegrini P; Berghella AM; Contasta I; Adorno D Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032 [TBL] [Abstract][Full Text] [Related]
17. Soluble immune receptor serum levels are associated with age, but not with clinical phenotype or disease severity in childhood atopic dermatitis. Ott H; Wilke J; Baron JM; Höger PH; Fölster-Holst R J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):395-402. PubMed ID: 19744181 [TBL] [Abstract][Full Text] [Related]
19. Serum measurement of thymus and activation-regulated chemokine/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis. Fujisawa T; Nagao M; Hiraguchi Y; Katsumata H; Nishimori H; Iguchi K; Kato Y; Higashiura M; Ogawauchi I; Tamaki K Pediatr Allergy Immunol; 2009 Nov; 20(7):633-41. PubMed ID: 19236603 [TBL] [Abstract][Full Text] [Related]
20. Changes of serum levels of interleukin-2, intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1 and Th1 and Th2 cell in severe atopic dermatitis after intravenous immunoglobulin therapy. Huang JL; Lee WY; Chen LC; Kuo ML; Hsieh KH Ann Allergy Asthma Immunol; 2000 Mar; 84(3):345-52. PubMed ID: 10752921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]